A Nurse-Led, Coping and Supportive Intervention for Patients With Triple-Negative Breast Cancer

Recruiting now · Not applicable

Conditions studied: Triple Negative Breast Cancer (TNBC)

In brief

The purpose of this study is to explore the feasibility and acceptability of a nurse-led, coping, and supportive care intervention for patients with triple-negative breast cancer. The intervention aims to improve psychosocial outcomes in patients with triple-negative breast cancer (e.g., quality of life (QOL), anxiety, fear of cancer recurrence (FCR)).

Key facts

Study ID

NCT07513311

Run by

Massachusetts General Hospital

People needed

75

Starts

2026-06-01

Expected to finish

2028-07-31

Last updated by the study team

2026-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of stage 1-3 triple-negative breast cancer
• Age ≥ to 18 years
• Between one and 12 months post curative therapy
• Reporting distress at least 4/10 on a one-item screener
• Ability to read and respond in English or Spanish

You may not qualify if…

• Patients with stage 4 cancer
• Patients with impaired cognition or serious mental illness that would preclude participation in study procedures

Where it is running

• Massachusetts General Hospital — Boston, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.